TrademarkOpen
Search / United States / 97157972

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

REPLICATE

Allowed — statement of use stage
Statement Of Use - To Examiner
Used for: Pharmaceutical and biologic preparations for the treatment of inflammatory disorders and diseases, and infectious…
Show more

Class 5: Pharmaceutical and biologic preparations for the treatment of inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response
Class 42: Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 9 Dec 2021
    Application filed
    New Application Entered
  2. 14 Sep 2022
    Assigned to an examining attorney
    Assigned To Examiner
  3. 26 Sep 2022
    Office action issued
    Non-Final Action Written
  4. 12 Jan 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 10 Feb 2023
    Approved for publication
    Approved For Pub - Principal Register
  6. 21 Mar 2023
    Published for opposition
    Published For Opposition
  7. 16 May 2023
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 20 May 2023
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 28 Mar 2024
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 23 Dec 2024
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
  11. 27 Apr 2026
    Statement of use filed
    Teas Statement Of Use Received
  12. 25 Aug 2026
    Assigned to an examining attorney
    Assigned To Examiner
All 39 events
2026-08-25Assigned To Examiner
2026-05-01Statement Of Use Processing Complete
2026-04-27Teas Statement Of Use Received
2026-04-27Use Amendment Filed
2025-11-21Notice Of Approval Of Extension Request E-Mailed
2025-11-20Sou Extension 5 Granted
2025-11-14Sou Teas Extension Received
2025-11-13Sou Extension 5 Filed
2025-05-16Sou Extension 4 Granted
2025-05-16Notice Of Approval Of Extension Request E-Mailed
2025-05-15Sou Teas Extension Received
2025-05-15Sou Extension 4 Filed
2024-12-23Sou Extension 3 Granted
2024-12-23Notice Of Approval Of Extension Request E-Mailed
2024-12-20Case Assigned To Intent To Use Paralegal
2024-11-12Sou Teas Extension Received
2024-11-12Sou Extension 3 Filed
2024-03-29Notice Of Approval Of Extension Request E-Mailed
2024-03-28Sou Teas Extension Received
2024-03-28Sou Extension 2 Filed
2024-03-28Sou Extension 2 Granted
2023-05-23Notice Of Approval Of Extension Request E-Mailed
2023-05-20Sou Teas Extension Received
2023-05-20Sou Extension 1 Filed
2023-05-20Sou Extension 1 Granted
2023-05-16Noa Mailed - Sou Required From Applicant
2023-03-21Published For Opposition
2023-03-21Official Gazette Publication Confirmation E-Mailed
2023-03-01Notification Of Notice Of Publication E-Mailed
2023-02-10Approved For Pub - Principal Register
2023-01-13Teas/Email Correspondence Entered
2023-01-12Teas Response To Office Action Received
2023-01-12Correspondence Received In Law Office
2022-09-26Non-Final Action Written
2022-09-26Non-Final Action E-Mailed
2022-09-26Notification Of Non-Final Action E-Mailed
2022-09-14Assigned To Examiner
2021-12-10New Application Office Supplied Data Entered
2021-12-09New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical and biologic preparations for the treatment of inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response

First use anywhere 0 Apr 2023 · First use in commerce 0 Aug 2023

Class 42 Technology & SaaS

Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases

First use anywhere 0 Nov 2025 · First use in commerce 0 Nov 2025

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 25 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.